Ablation of supraventricular tachycardia in elderly persons presents a challenging problem to electrophysiologists. Friable cardiac structures, prone to catheter perforation, comorbid cardiovascular ...

Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...

A recent study published in Pacing and Clinical Electrophysiology (PACE) determined that the use of catheter ablation to treat supraventricular tachycardia (SVT) is not detrimental to patients. This ...

The Supraventricular Tachycardia market benefits from aging populations, technological advances like catheter ablation, rising cardiovascular awareness, and wearable diagnostics. Growth is supported ...

Deltona, Fla.-based Advanced Heart and Vascular Surgery Center, an affiliate of Cardiovascular Centers of America, has become the first ASC in Florida to launch a complete cardiac ablation service ...

In a proof of concept study, scientists at Johns Hopkins report they have successfully created personalized, 3-D virtual simulations of patients' hearts for doctors to visualize and perform a ...

Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...

Ablation of ventricular tachycardia is a proven treatment for arrhythmias in patients with a history of heart attacks. Identifying the area of the increased scar tissue that is responsible for the ...

The cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and demographic factors. As cardiac ...